Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review (Q38374279)

2 September 2017

1 reference

title

Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review (English)

1 reference

2 September 2017

0 references

0 references

Sebastian Schneeweiss

4

object named as

Sebastian Schneeweiss

1 reference

2 September 2017

8

John D Seeger

1 reference

2 September 2017

Elisabetta Patorno

1

1 reference

2 September 2017

Elizabeth M Garry

2

1 reference

2 September 2017

Amanda R Patrick

3

1 reference

2 September 2017

Victoria G Gillet

5

1 reference

2 September 2017

Olesya Zorina

6

1 reference

2 September 2017

Dorothee B Bartels

7

1 reference

2 September 2017

publication date

1 March 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

38

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

295-310

1 reference

A review of uses of health care utilization databases for epidemiologic research on therapeutics

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

A basic study design for expedited safety signal evaluation based on electronic healthcare data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Immortal time bias in pharmaco-epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Relationship between cumulative dose of thiazolidinediones and clinical outcomes in type 2 diabetic patients with history of heart failure: a population-based cohort study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Effects of thiazolidinediones on cardiovascular events in patients with type 2 diabetes mellitus after drug-eluting stent implantation: a retrospective cohort study using the national health insurance database in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Insulin use and increased risk of mortality in type 2 diabetes: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Risk of Cardiovascular Events and All-Cause Mortality in Patients Treated With Thiazolidinediones in a Managed-Care Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Overadjustment bias and unnecessary adjustment in epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Cancer risk in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

The incident user design in comparative effectiveness research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Beyond the intention-to-treat in comparative effectiveness research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Marginal structural models and causal inference in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Channeling bias in the interpretation of drug effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Diabetes and cancer: a consensus report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Metformin use is associated with better survival of diabetic patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Rosiglitazone is associated with mortality in chronic hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

A simulation study of the number of events per variable in logistic regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

The central role of the propensity score in observational studies for causal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Metrics for covariate balance in cohort studies of causal effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Comorbidity as a predictor of stage of illness for patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Diabetes and risk of bladder cancer: evidence from a case-control study in New England

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases: A Simulation Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40264-015-0280-1

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

21 January 2018

1 reference

12 December 2020

Confounding by indication

1 reference

12 December 2020

Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study

1 reference

12 December 2020

Recall accuracy for prescription medications: self-report compared with database information

1 reference

12 December 2020

Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation

1 reference

12 December 2020

Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study

1 reference

12 December 2020

Observational studies of drugs and mortality

1 reference

12 December 2020

Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy

1 reference

12 December 2020

Quantifying biases in causal models: classical confounding vs collider-stratification bias.

1 reference

12 December 2020

Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes

1 reference

12 December 2020

The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus

1 reference

12 December 2020

Screening mammogram utilization in women with diabetes

1 reference

12 December 2020

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

1 reference

12 December 2020

The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure

1 reference

12 December 2020

The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis

1 reference

12 December 2020

What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes

1 reference

12 December 2020

Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort

1 reference

12 December 2020

Record linkage studies for postmarketing drug surveillance: data quality and validity considerations.

1 reference

12 December 2020

Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis

1 reference

12 December 2020

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

12 December 2020

Sulfonylurea drugs do not influence initial stroke severity and in-hospital outcome in stroke patients with diabetes

1 reference

12 December 2020

Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up

1 reference

12 December 2020

Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders

1 reference

12 December 2020

Randomized trials analyzed as observational studies

1 reference

12 December 2020

Completeness of prescription recording in outpatient medical records from a health maintenance organization

1 reference

12 December 2020

10.1007/S40264-015-0280-1

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1016094536

0 references

1 reference